Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 6-7, 2006, Pages 823-827

  Elias, Dominique ^a   Di Pietroantonio, Daniela ^a   Gachot, Bertrand ^a   Menegon, Paola ^a   Hakime, Antoine ^a   De Baere, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; GENTAMICIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM IDENTIFICATION; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENDOCRINE TUMOR; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; LIVER ABSCESS; LIVER TUMOR; MALE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME;

EID: 33746886607     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73327-9     Document Type: Article

References (25)

1. Livraghi T, Solbiati L, Meloni MF, Gazelle S, Halpern EF, Goldberg N. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.
2. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-22.
3. Decadt B, Siriwardena A. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004;5:550-60.
4. de Baere T, Risse O, Kuoch V, Dromain C, Smayra T, Gamal el Din M, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003;181:695-700.
5. Shibata T, Yamamoto Y, Yamamoto N, Maetani Y, Shibata T, Ikai Y, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 2003;14:1535-42.
6. Kim W, Clarck TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:965-8.
7. Warren KW, Hardy KJ. Pyogenic liver abscess. Arch Surg 1968;97:40-5.
8. Carrel TP, Matthews JB, Baer HU, Blumgart LH. Etiologie, diagnostic et traitement des abcès hépatiques après chirurgie biliaire. Ann Chir 1990;44:746-51.
9. Kubo S, Kinoshita S, Hiroashi K, Tanaka H, Tsukamoto T, Kanazawa A. Risk factor for and clinical findings of liver abscess after biliary-intestinal anastomosis. Hepato-Gastroenterol 1999;46:116-20.
10. Pennington L, Kauf man S, Cameron JL. Intrahepatic abscess as a complication of long term percutaneous internal biliary drainage. Surgery 1982;91:642-6.
11. Huang CJ, Pitt HA, Lipsset P, Osterman FA, Lillemoe KD, Cameron JL, et al. Pyogenic abscess, changing trends over 42 years. Ann Surg 1996;223:600-9.
12. Sung JY, Costerton GW, Shaffer EA. Defense system in biliary tract against bacterial infection. Dig Dis Sci 1992;37:689-96.
13. Bergman JJ, van Berkel AM, Groen AK, Schoeman MN, Offerhaus J, Tytgat GN, et al. Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy. Gastrointest Endosc 1997;45:400-5.
14. Tanaka M, Takahata S, Konomi H, Matsunaga H, Yokohata K, Takeda T, et al. Long-term consequences of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc 1998;48:540-2.
15. Chuang JH, Chen WJ, Lee SY, Chang NK. Prompt colonization of the hepaticojejunostomy and translocation of bacteria to liver after bile duct reconstruction. J Pediatr Surg 1998;33:1125-31.
16. Chuang JH, Lee SY, Chen WJ, Hsieh CS, Chang NK, Lo SK. Changes in bacterial concentration of the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction: implication in the pathogenesis of postoperative cholangitis. World J Surg 2001;25:1512-18.
17. Hochwald SN, Burke EC, Jarnagin WR, Fong Y, Blumgart L. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangicarcinoma. Arch Surg 1999;134:261-6.
18. Marchal F, Elias D, Rauch P, Leroux A, Stinés J, Verhaegue JL, et al. Biliary lesions during radiofrequency ablation in liver. Eur Surg Res 2004;36:88-94.
19. Leblanc A, Proux MC, Odievre M. Bacterial analysis of jejunostomy fluid after surgery of extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1983;2:307-11.
20. Lorenz R, Herrmann M, Kassem AM, Lehn N, Neuhaus H, Classen M. Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system. Endoscopy 1998;30:708-12.
21. Brody LA, Brown KT, Getrajdman GI, Kannegieter LS, Brown AE, Fong Y, et al. Clinical factors associated with positive bile cultures during primary percutaneous drainage. JVIR 1998;9:572-8.
22. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprothesis. Gastrointest Endosc 2002;56:885-9.
23. Geschwind JF, Kaushik S, Ramsay DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolozation treatment of liver tumors. J Vasc Interv Radiol 2002;13:1163-6.
24. Bassotti G, Chistolini F, Sietchiping-Nzepa F, de Roberto G, Morelli A. Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections. World J Gastroenterol 2004;10:2281-3.
25. Del Favero,A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, et al. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutopenia. Clin Infect Dis 2001;33:1295-301.